Resultats de la cerca - Eric Lowe
- Mostrar 1 - 10 resultats de 10
-
1
-
2
Intensive chemotherapy for systemic anaplastic large cell lymphoma in children and adolescents: Final results of children's cancer group study 5941 per Eric Lowe, Richard Sposto, Sherrie L. Perkins, Thomas G. Gross, Jonathan L. Finlay, David L. Zwick, Minnie Abromowitch
Publicat 2008Artigo -
3
Childhood anaplastic large cell lymphoma has a high incidence of <i>ALK</i> gene rearrangement as determined by immunohistochemical staining and fluorescent <i>in situ</i> hybridis... per Sherrie L. Perkins, Diane L. Pickering, Eric Lowe, David L. Zwick, Minnie Abromowitch, Ginny Davenport, Mitchell S. Cairo, Warren G. Sanger
Publicat 2005Artigo -
4
Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1 per Eric Lowe, Anne F. Reilly, Megan S. Lim, Thomas G. Gross, Lauren Saguilig, Donald A. Barkauskas, Rui Wu, Sarah Alexander, Catherine M. Bollard
Publicat 2021Artigo -
5
Crizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1 per Eric Lowe, Anne F. Reilly, Megan S. Lim, Thomas G. Gross, Lauren Saguilig, Donald A. Barkauskas, Rui Wu, Sarah Alexander, Catherine M. Bollard
Publicat 2022Artigo -
6
Advanced stage anaplastic large cell lymphoma in children and adolescents: Results of ANHL0131, a randomized phase III trial of APO versus a modified regimen with vinblastine: A re... per Sarah Alexander, Jacqueline M. Kraveka, Sheila Weitzman, Eric Lowe, Lynette M. Smith, James C. Lynch, Myron Chang, Marsha C. Kinney, Sherrie L. Perkins, Joseph Laver, Thomas G. Gross, Howard J. Weinstein
Publicat 2014Artigo -
7
Signal peptide mimicry primes Sec61 for client-selective inhibition per Shahid Rehan, Dale Tranter, Phillip P. Sharp, Gregory B. Craven, Eric Lowe, Janet L. Anderl, Tony Muchamuel, Vahid Abrishami, Suvi Kuivanen, Nicole A. Wenzell, Andy Jennings, Chakrapani Kalyanaraman, Tomas Strandin, Matti Javanainen, Olli Vapalahti, Matthew P. Jacobson, Dustin McMinn, Christopher J. Kirk, Juha T. Huiskonen, Jack Taunton, Ville O. Paavilainen
Publicat 2023Artigo -
8
Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era per Lianna J. Marks, Victor Ritter, Jennifer E. Agrusa, Kala Y. Kamdar, Julie Rivers, Rebecca Gardner, Matthew J. Ehrhardt, Kaitlin J. Devine, Charles Phillips, Anne F. Reilly, Keith J. August, Joanna Weinstein, Prakash Satwani, Christopher J. Forlenza, Christine M. Smith, Chelsee Greer, Zeinab Afify, Carol Lin, Jennifer A. Belsky, Hilda Ding, David J. Hoogstra, Keri Toner, Michael P. Link, Liora M. Schultz, Eric Lowe, Catherine Aftandilian
Publicat 2025Artigo -
9
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies per Andrew D.J. Pearson, Elly Barry, Yaël P. Mossé, Franca Ligas, Nick Bird, Teresa de Rojas, Zachary Zimmerman, Keith D. Wilner, Willi Woessmann, Susan Weiner, Brenda J. Weigel, Rajkumar Venkatramani, D Valteau, Toby N. Trahair, Malcolm A. Smith, Sonia Singh, Giovanni Selvaggi, Nicole Scobie, Gudrun Schleiermacher, Nicholas C. Richardson, Julie Park, Karsten Nysom, Koen Norga, Margret Merino, Joe McDonough, Yousif Matloub, Lynley V. Marshall, Eric Lowe, Giovanni Lesa, Meredith S. Irwin, Dominik Karres, Amar Gajjar, François Doz, Elizabeth Fox, Steven G. DuBois, Martha Donoghue, Michela Casanova, Hubert Caron, Victoria Buenger, Diana Bradford, P. Blanc, Amy Barone, Gregory H. Reaman, Gilles Vassal
Publicat 2021Revisão -
10
Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism per Neil A. Goldenberg, John M. Kittelson, Thomas C. Abshire, Marc P. Bonaca, James F. Casella, Rita Dale, Jonathan L. Halperin, Frances Hamblin, Craig M. Kessler, Marilyn J. Manco‐Johnson, Robert F. Sidonio, Alex C. Spyropoulos, Philippe Gabríel Steg, Alexander G.G. Turpie, Sam Schulman, James A. French, John H. Fargo, Shelley E. Crary, Riten Kumar, Rachel F. Grace, Cameron C. Trenor, Hope P. Wilson, Lee Hilliard, Gary Woods, Kavita Patel, Neil A. Goldenberg, Eric Lowe, Julie Jaffray, Guy Young, Madhvi Rajpurkar, Jennifer Davila, Arash Mahajerin, James Cooper, Sriya Gunawardena, Ayesha Zia, Janna M. Journeycake, Shannon L. Carpenter, Michael M Guerrera, Yaser Diab, Cristina Tarango, Ralph A. Gruppo, Suchitra S. Acharya, Marcella D Torres, Linda Shaffer, Robert C. Mignacca, Kristina M. Haley, Michael Recht, Courtney D. Thornburg, Nirmish Shah, Craig A. Mullen, Deanna Mitchell, Charles Nakar, Marisol Betensky, Courtney E. Lawrence, Clifford M. Takemoto, Clara Lo, Ajovi B. Scott‐Emuakpor, Roshni Kulkarni, Alexandra J. Borst, Sarah H. O’Brien, Fernando F Corales-Medina, Shalu Narang, Nicole Kucine, Michael Wang, Arun Panigrahi, Kerry McGowan, Stuart L. Cramer, Smita C. Dandekar, Frederico Xavier, Kristina M Knoll, Anupam Verma, A. Geddes, Sanjay Ahuja, Kerry Hege, Deepti Raybagkar, Anjali Sharathkumar, Lakshmi V Srivath, Osman Khan, Colleen Druzgal, Mihir D. Bhatt, Anthony K.C. Chan, Leonardo R. Brandão, Patricia Massicotte, C. Heleen van Ommen, Christoph Male, Paul Monagle, Taizo A. Nakano, William B. Mitchell, William R. Hiatt, Jeffrey I. Weitz
Publicat 2022Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Oncology
Anaplastic large-cell lymphoma
Anaplastic lymphoma kinase
Chemotherapy
Lymphoma
Malignant pleural effusion
Biology
Genetics
Lung cancer
Crizotinib
Gastroenterology
Gene
Surgery
ALK inhibitor
Brentuximab vedotin
Cancer
Cancer research
Chemotherapy regimen
Cyclophosphamide
Prednisone
Regimen
Vincristine
Antibody
Anticoagulant therapy
Asparaginase
Astrobiology
Atrial fibrillation
Biochemistry